Mitomics, One of the Top 10 Life Sciences Companies in Canada, Selects Exemplar LIMS for CLIA Compliant US based Lab
Mitomics, One of the Top 10 Life Sciences Companies in Canada, Selects Exemplar LIMS for CLIA Compliant US based Lab
Baltimore, MD – December 15, 2010 – Sapio Sciences is pleased to announce that Mitomics has selected Exemplar LIMS as its Laboratory Information Management Solution (LIMS). Sapio was chosen because of our experience in rapidly implementing CLIA compliant LIMS. Mitomics will utilize Exemplar LIMS in its Colorado based lab for:
¨ Tracking sample processing requests from physicians via the web as well as associated payment and patient information
¨ Tracking Laboratory Sample Processing Workflows
¨ Compliance with CLIA specifications for quality standards related to laboratory testing to ensure the accuracy, reliability and timeliness of patient test results
¨ Results tracking and delivery to requesting physicians
“We are gratified that one of the premier life sciences companies in Canada has chosen Exemplar LIMS for their new CLIA laboratory. Through the use of our Exemplar LIMS solution, Sapio can implement compliant solutions in unprecedented timeframes, while assuring the quality standards set forth by CLIA are met ,”says Julia Neel,Chief Software Architect at Sapio.“We look forward to working with the Mitomics team in support of their important diagnostics applications.”
For more information or to schedule a product demonstration, visit http://www.SapioSciences.com .
About Sapio Sciences Llc
Sapio Sciences is a leading provider of LIMS and Data Management software, enabling scientists to manage samples, protocols, assay data and clinical trials. Exemplar LIMS breaks new ground in its breadth of functionality and ease of configuration. With built-in Sample Management, Step-by-Step protocol tracking (ELN), data management and integrated analytics, Exemplar LIMS addresses
the full life cycle of samples from receipt to processing and analysis. Sapio will continue to lead in ease of use and breadth of functionality across its product line, enabling organizations to reduce costs while increasing productivity and efficiency of both laboratories and researchers alike. Sapio has strong working relationships with leading platform vendors such as Affymetrix, Illumina and Applied Biosystems ensuring compatibility with technology from these leading companies.
About Mitomics
Mitomics is pioneering the development of molecular tests based on the mitochondrial genome in order to improve clinical insight and therapeutic decisions that affect patients worldwide. In 2010, the company launched its novel, paradigm-shifting Prostate Core Mitomic Test ™ to identify men at high risk of having a prostate tumor missed by the prostate biopsy procedure, without the need for further invasive biopsy procedures. Mitomics plans to launch several additional products based on its Mitomic Technology ™ over the next two years.
Mitomics was founded in 2001 as Genesis Genomics and has since established itself as a leader in the science of mtDNA. Based in Thunder Bay, Ontario, the company is led by a team of business executives and world-class scientists with significant experience in discovering and developing innovative molecular-based products.
